What is the recommended dosage and usage of Senna (sennosides) for treating constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Senna Dosing and Usage for Constipation

Start senna at 8.6-17.2 mg (1-2 standard tablets) once daily at bedtime, titrating upward based on response, with a goal of achieving one non-forced bowel movement every 1-2 days. 1, 2

Initial Dosing Strategy

  • Begin with 8.6-17.2 mg daily (equivalent to 1-2 standard commercial tablets of 8.6 mg each) taken at bedtime 1, 2
  • The FDA-approved liquid formulation contains 8.8 mg sennosides per 5 mL (1 teaspoon), with adults taking 2-3 teaspoons (10-15 mL) once daily 3
  • Senna should be combined with polyethylene glycol (MiraLAX) 17 grams once daily as first-line therapy, as the American Gastroenterological Association recommends this combination approach 4

Dose Titration and Maximum Dosing

  • Increase the dose gradually if inadequate response occurs, monitoring for cramping and diarrhea which indicate the need for dose reduction 4, 2
  • The maximum FDA-approved dose is 3 teaspoons (15 mL) twice daily for liquid formulations 3
  • Standard practice allows up to 4 tablets twice per day, though no clear maximum dose is established in guidelines 1
  • In palliative care settings for severe constipation, doses may be escalated to 2-3 tablets two to three times daily 4, 2

Mechanism and Timing of Action

  • Senna contains anthranoid compounds that require hydrolysis by colonic bacteria to become active, producing both motor stimulation of peristalsis and secretory effects 2
  • Antibiotics may reduce senna's efficacy since gut bacteria are required for activation 4
  • Take at bedtime to produce a bowel movement the following morning 3

Duration of Use and Safety Profile

  • The American Gastroenterological Association recommends senna primarily for short-term use (4 weeks or less) or as rescue therapy 1, 2
  • Long-term safety data are limited, though extended use may be appropriate in select cases such as palliative care 1, 2
  • There is no convincing evidence that chronic senna use causes structural damage to enteric nerves, smooth muscle ("cathartic colon"), or increases colorectal cancer risk 5
  • Senna is not carcinogenic in animal studies even at doses up to 300 mg/kg/day for two years 5

Common Side Effects and Management

  • Abdominal cramping, pain, and diarrhea are the most common side effects, particularly at higher doses 1, 2
  • Clinical trials using 1 gram daily (10-12 times higher than standard commercial tablets) resulted in 83% of participants reducing their dose due to side effects 4
  • Perineal blistering can occur rarely (2.2% incidence) with higher doses (≥60 mg/day), prolonged stool-to-skin contact, or nighttime accidents—advise frequent diaper changes in non-toilet-trained children 6
  • Prolonged or excessive use can cause electrolyte imbalances 1

Special Populations

  • In chronic kidney disease, senna is safe with over 90% fecal excretion, making it preferable to magnesium-based laxatives 4
  • Senna may be too strong for overtly weak or debilitated patients 2
  • For children ages 6-12 years, use 1 to 1.5 teaspoons (5-7.5 mL) once daily; ages 2-6 years use 0.5 to 0.75 teaspoons (2.5-3.75 mL) once daily 3
  • Consult a physician for children under 2 years of age 3

When to Escalate or Change Therapy

  • If the MiraLAX-senna combination fails after appropriate titration, consider bisacodyl 5-10 mg for short-term or rescue use 4
  • Evaluate for fecal impaction and rule out mechanical obstruction before escalating 4
  • For refractory cases, consider prescription secretagogues such as lubiprostone (24 μg twice daily), linaclotide (72-145 μg daily), or plecanatide (3 mg daily) 1, 4

Quality of Life Benefits

  • Senna significantly improves quality of life scores compared to placebo, with a mean difference of 7.80 points 4
  • Response rates show 567 more responders per 1,000 patients treated with senna versus placebo 4

Critical Contraindications

  • Do not use in intestinal obstruction or ileus, severe dehydration, or acute inflammatory bowel conditions 4
  • Avoid in patients with known hypersensitivity to senna or sennosides 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Senna Dosage and Administration for Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bowel Regimen Management with MiraLAX and Senna

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.